H. Loong
3 Papers
H. Loong is an academic researcher. The author has contributed to research in topics: Medicine & Public health. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
312P ClinMatch: A clinical trial matching platform that improves trial accessibility among NSCLC patients through comprehensive genomic and clinical profiling
A. Yu,Aldrin Kay-Yuen Yim,Sf F. Nyaw,K.K. Li,Y. Lau,S.C.M. Li,Spencer Mok,G. Tang,A. Chang,Vincent Prêtre,Ningning Jin,Alan Ka-Lun Kai,Tsunehiko Kan,H.C. Lee,T. Chan,C. Wong,W. Cho,H. Loong +17 more
TL;DR: In this article , an automated decision support system coupled with comprehensive genomic profiling (CGP) is proposed to increase clinical trials recruitment and reduce screen failure rates, which may improve the quality of clinical trials.
2
Global Health System Resilience during Encounters with Stressors – Lessons Learnt from Cancer Services during the COVID-19 Pandemic
K G Yeoh,Yusheng Wu,S. Chakraborty,Gamal El-Husseiny,Soehartati Gondhowiardjo,Nakita Joseph,A. Lee,H. Loong,Susan Citonje Msadabwe-Chikuni,B.F. Tan,A.V. Ospina,T. Roques,H. Shum,Eng-Kiong Yeoh +13 more
TL;DR: In this paper , the authors investigated aspects of health system resilience in maintaining cancer services globally during the COVID-19 pandemic and identified four key points/recommendations to enhance the resilient capacity of cancer care.
424P MD Anderson Cancer Center global precision oncology decision support (Glo-PODS) clinical trial genomic support: Pilot program at the Prince of Wales Hospital (Chinese University of Hong Kong - CUHK)
B.B.Y. Ma,A. Johnson,K.R. Mills Shaw,H. Loong,F. Mo,R.N. Lui,K.H. Wong,Z. Zeng,V. Holla,M. Kahle,T. Vu,F. Su,S-H. Kim,T. Conway,Q. Wang,W. Tao,L. Zhou,J. Rodon,F. Meric-Bernstam,Timonthy A Yap +19 more
TL;DR: A pilot study (Glo-PODS) at the Chinese University of Hong Kong evaluated the MD Anderson Precision Oncology Decision Support (PODS) system, which annotated genomic alterations to guide clinical decisions and trial enrollment in 144 Chinese patients with GI cancers.